Exacerbation of myasthenia gravis after removal of a thymoma having a membrane phenotype of suppressor t cells
- 1 April 1984
- journal article
- case report
- Published by Wiley in Annals of Neurology
- Vol. 15 (4), 400-402
- https://doi.org/10.1002/ana.410150416
Abstract
We describe a case of myasthenia gravis associated with a thymoma having a membrane phenotype of suppressor T cells, as defined by monoclonal antibodies. Thymectomy resulted in exacerbation of the disease, a drastic increase in serum acetylcholine receptor‐antibody titer, and a decrease of the circulating suppressor T cell population. The findings indicate that the etiopathogenic relationship between the thymus and myasthenia gravis is variable and complex.Keywords
This publication has 10 references indexed in Scilit:
- Cell lineage in lymphoproliferative diseaseAmerican Journal Of Medicine, 1983
- Immunologic classification of lymphocytic leukemias based on monoclonal antibody-defined cell surface antigensBlood, 1982
- Immunocytochemical localization of thymosin-α1 in thymic epithelial cells of normal and myasthenia gravis patients and in thymic culturesJournal of the Neurological Sciences, 1981
- Myasthenia gravisNeurology, 1980
- Discrete stages of human intrathymic differentiation: Analysis of normal thymocytes and leukemic lymphoblasts of T-cell lineageProceedings of the National Academy of Sciences, 1980
- MYASTHENIA GRAVIS IN PATIENTS WITH THYMOMA, WITH PARTICULAR REFERENCE TO ONSET AFTER THYMECTOMYMedicine, 1978
- IN-VITRO SYNTHESIS OF ANTI-ACETYLCHOLINE-RECEPTOR ANTIBODY BY THYMIC LYMPHOCYTES IN MYASTHENIA GRAVISThe Lancet, 1978
- Thymic Muscle Cells Bear Acetylcholine Receptors: Possible Relation to Myasthenia GravisScience, 1977
- Antibody to acetylcholine receptor in myasthenia gravisNeurology, 1976
- Serum Globulin in Myasthenia Gravis: Inhibition of α-Bungarotoxin Binding to Acetylcholine ReceptorsScience, 1974